Key Takeaways The rapid expansion of and access to GLP-1 receptor agonist (RA) weight-loss medications may be outpacing researchers’ ability to fully understand how these drugs interact with other treatments, prompting renewed calls for additional research at a time when federal support for biomedical research faces increased uncertainty. A recent BBC Science Focus Magazine report […]
Key Takeaways The rapid expansion of and access to GLP-1 receptor agonist (RA) weight-loss medications may be outpacing researchers’ ability to fully understand how these drugs interact with other treatments, prompting renewed calls for additional research at a time when federal support for biomedical research faces increased uncertainty. A recent BBC Science Focus Magazine report […]
